ISCOOTCPharmaceutical PreparationsFiscal year ends December 31

International Stem Cell CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.28+0.00 (+0.89%)

Close on Oct 19, 2026

Market cap: $2.27M
P/E (TTM): –
Dividend yield: –

International Stem Cell CORP balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31	FY 2006 2006-12-31
Cash & Equivalents	0.99	1.23	1.59	0.74	0.17	0.69	0.48	1.08	0.30	0.11	0.53	1.11	2.24	0.65	1.34	5.78	0.73	–	–	–
Cash & Short-Term Investments	0.99	1.23	1.59	0.74	0.17	0.69	0.48	1.08	0.30	0.11	0.53	1.11	2.24	0.65	1.34	5.78	0.73	–	–	–
Receivables	0.72	1.06	0.57	0.75	0.84	0.40	1.52	0.65	0.47	0.57	0.54	0.45	0.31	0.27	0.14	0.74	–	–	–	–
Inventory	1.51	1.15	1.26	1.38	1.18	0.92	1.25	1.50	1.31	1.39	1.35	1.52	1.37	1.20	1.27	0.86	–	–	–	–
Prepaid Expenses & Other	0.18	0.12	0.10	0.09	0.14	0.17	0.21	0.54	0.78	0.42	0.57	0.49	0.66	0.46	0.27	0.23	–	–	–	–
Other Current Assets	0.01	0.01	0.02	0.03	0.02	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Assets	3.41	3.56	3.52	2.96	2.33	2.18	3.45	3.77	2.86	2.49	2.99	3.62	4.63	2.58	3.02	7.61	–	–	–	–
Property, Plant & Equipment	0.16	0.26	0.22	0.25	0.38	0.53	0.67	0.47	0.32	0.40	0.38	0.71	0.83	1.13	1.42	1.30	–	–	–	–
Gross Property, Plant & Equipment	2.61	2.58	2.54	2.47	2.51	3.44	3.41	3.12	2.91	2.82	2.62	2.61	2.36	2.47	2.36	–	–	–	–	–
Accumulated Depreciation	-2.45	-2.33	-2.33	-2.22	-2.12	-2.90	-2.74	-2.65	-2.59	-2.43	-2.25	-1.90	-1.53	-1.34	-0.94	–	–	–	–	–
Operating Lease Right-of-Use Assets	0.34	0.35	0.56	0.73	0.87	0.87	0.72	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.64	0.72	0.80	0.88	0.95	1.26	1.34	2.67	2.92	3.48	3.22	2.80	2.25	1.63	1.28	0.99	–	–	–	–
Deferred Tax Assets	–	–	–	–	–	–	–	–	0	0	0.03	0.02	0.01	0.02	–	–	–	–	–	–
Total Assets	4.82	5.17	5.39	5.14	4.95	5.29	6.62	7.80	6.86	7.05	7.14	7.18	7.74	5.37	5.74	9.93	–	–	–	–
Accounts Payable	0.17	0.19	0.36	0.32	0.51	0.36	0.65	0.46	0.83	0.84	1.09	0.67	0.53	0.97	–	–	–	–	–	–
Accrued Expenses	0.43	0.53	0.49	0.51	0.40	0.39	0.64	0.58	0.61	0.47	0.83	1.71	1.29	0.73	–	–	–	–	–	–
Current Portion of Leases	0.39	0.33	0.28	0.23	0.18	0.35	0.37	–	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	–	–	–	–	–	–	0	0	0.00	0.23	0.19	0.76	–	–	–	–
Total Current Liabilities	4.58	4.69	4.83	4.64	4.28	1.48	1.91	5.08	4.80	3.60	5.54	6.86	7.02	2.19	2.11	4.54	–	–	–	–
Long-Term Leases	0	0.12	0.45	0.72	0.95	0.85	0.72	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	0.39	0.45	0.72	0.95	1.13	1.19	1.09	–	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	–	–	0	0	0.03	0.02	0.01	0.02	–	–	–	–	–	–
Total Liabilities	4.58	4.80	5.28	5.36	5.23	5.32	5.21	5.26	4.80	3.60	5.54	6.86	12	7.13	2.11	4.54	–	–	–	–
Preferred Stock	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.00	–	–	–	–
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.15	0.09	0.08	0.08	–	–	–	–
Additional Paid-In Capital	107	107	106	106	105	105	103	109	107	102	99	95	78	70	64	56	–	–	–	–
Retained Earnings	-111	-111	-110	-110	-110	-109	-106	-107	-105	-98	-97	-95	-82	-72	-60	-51	–	–	–	–
Shareholders' Equity	-4.06	-3.93	-4.19	-4.52	-4.59	-4.33	-2.89	2.54	2.06	3.44	1.59	0.32	-4.22	-1.76	3.62	5.39	-2.27	0.43	0.21	4.70
Total Equity	-4.06	-3.93	-4.19	-4.52	-4.59	-4.33	-2.89	2.54	2.06	3.44	1.59	0.32	-4.22	-1.76	3.62	5.39	-2.27	0.43	0.21	4.70
Total Liabilities & Equity	4.82	5.17	5.39	5.14	4.95	5.29	6.62	7.80	6.86	7.05	7.14	7.18	7.74	5.37	5.74	9.93	–	–	–	–
Shares Outstanding(shares)	8.00	8.00	8.00	8.00	8.00	7.54	7.54	6.93	6.06	3.95	2.81	1.60	1.01	0.58	0.53	0.50	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 55.0%
Operating margin: -4.7%
Net margin: -6.1%
Return on equity, FY2025: 10.5%

Financial strength

Current ratio: 0.79
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 21.8%

Valuation

P/E ratio: –
Price to sales: 0.24
Price to book: –
Dividend yield: –